Despite advantages of bodily exercise, the extent of bodily exercise shouldn’t be fascinating in sufferers with sort 2 diabetes. The purpose of this research is the utilizing of integration of intervention primarily based on the speculation of safety motivation and implementation intention so as to enhance the extent of exercise in sufferers with diabetes.
This discipline trial research has been carried out on 125 sufferers with sort 2 diabetes. Samples have been randomly chosen, and they’re divided into two intervention and management teams. In the intervention group, coaching classes have been performed primarily based on the safety motivation principle and implementation intention.
Physical exercise ranges, VO2 max, and hemoglobin A1C have been measured earlier than and three months after the intervention within the two teams. Data have been analyzed through the use of SPSS 18, and impartial t-test, paired t-test, and equal nonparametric exams have been used for analyzing irregular information. The outcomes of this research confirmed that the extent of bodily exercise was increased within the intervention group (p = 0.02).
Also, the quantity of hemoglobin A1c within the intervention group has been decreased considerably three months later (p < 0.001). In this research, VO2 max and blood lipids weren’t considerably completely different within the two teams. However, there was increased VO2 max in contrast to earlier than the intervention within the intervention group.
The current research confirmed that combining motivational interventions and implementing intention intervention could be efficient in selling the bodily exercise of sufferers with sort 2 diabetes.
Association between sort 2 diabetes and osteoporosis danger: A consultant cohort research in Taiwan
Although earlier research have investigated the connection between fracture danger and sort 2 diabetes (T2D), cohort research that estimate composite osteoporosis danger are missing. This retrospective cohort research sought to decide the danger of osteoporosis in Taiwanese sufferers with T2D. Patients recognized with T2D between 2002 and 2015 recognized via the 2002 Taiwan Survey of Hypertension, Hyperglycemia, and Hyperlipidemia have been included.
A complete of 1690 males and 1641 girls aged ≥40 years linked to the National Health Insurance Research Database (NHIRD) have been adopted up to the tip of 2015 to determine the incidences of osteoporosis via ICD9-CM codes for osteoporosis or osteoporotic fractures or utilization of anti-osteoporotic brokers in accordance to Anatomical Therapeutic Chemical codes decided from NHIRD.
The particular person 12 months strategy and Kaplan-Meier evaluation have been then used to estimate the incidences and cumulative occasion charges, whereas the Cox proportional hazard mannequin was used to calculate adjusted hazard ratios (HR) for osteoporosis occasions.
A complete of 792 new osteoporosis occasions have been documented over a median follow-up period of 13.6 years. Participants with T2D had increased osteoporosis danger [adjusted HR: 1.37, 95% confidence interval (CI): 1.11-1.69] in contrast with these with out T2D. Subgroup analyses revealed that age had a slightly vital impact, indicating that T2D had a extra pronounced impact on osteoporosis danger in youthful inhabitants (<65 years outdated).
No distinction was discovered between sufferers stratified in accordance to intercourse. In conclusion, T2D was considerably related with elevated osteoporosis danger, particularly in youthful individuals.

Predictive Factors and Amputation Level for Reamputation in Patients With Diabetic Foot: A Retrospective Case-Control Study
The purpose of this research was to assess the speed and stage of reamputation in sufferers who had a earlier amputation from diabetic foot. We retrospectively analyzed sufferers who underwent amputation and reamputation due to diabetic foot in our clinic between 2011 and 2019. Fifty-nine have been evaluated because the healed group after the primary amputation and 55 have been evaluated because the reamputation group. Given 55 sufferers who wanted reamputation: there have been 13 finger or ray, 23 transmetatarsal or syme, 18 transtibial, and 1 transfemoral within the first operation. We discovered the reamputation price was 65.4% in distal amputations.
When serum parameters have been examined earlier than the primary amputation in every group, there was no statistically vital distinction in white blood cells, neutrophils, lymphocytes, platelets, sedimentation, C-reactive protein, complete protein, hematocrit, urea, creatinine, and HgA1c values.
There was, nevertheless, a big distinction between teams in albumin ranges. When comorbidities have been assessed for smoking, hypertension, period of diabetes, and quantity of debridements after the primary surgical procedure, a big distinction between teams was discovered.
When peripheral artery illness and continual renal failure have been examined, no vital distinction was noticed. In our research, it was noticed that the speed of reamputation was increased in distal stage amputations for diabetic foot sufferers. Accordingly, albumin values, smoking, hypertension, period of diabetes, quantity of debridements after surgical procedure, have been seen as danger components for reamputation sufferers.
National developments within the prevalence of glycemic management amongst sufferers with sort 2 diabetes receiving steady care in Thailand from 2011 to 2018
Diabetes is one of the most important international well being issues and reveals a continuously growing development. A collection of nationwide hospital-based cross-sectional surveys of medical outcomes was carried out yearly from 2011 to 2015 and 2018 amongst sufferers with sort 2 diabetes aged ≥ 20 years receiving medical look after no less than 12 months.
A two-stage stratified cluster that was proportional to the dimensions sampling method was used to choose a nationally and provincially consultant pattern of sufferers with sort 2 diabetes in Thailand. A complete of 186,010 sufferers with sort 2 diabetes have been enrolled within the research from 2011 to 2018. The prevalence of satisfactory glycemic management (hemoglobinA1c stage < 7.0%) amongst sufferers with sort 2 diabetes have been estimated to be 34.5% (95%CI 33.8-35.2%) in 2011, 33.0% (95%CI 32.4-33.6%) in 2012, 34.7% (95%CI 34.1-35.4%) in 2013, 35.5 (95%CI 34.9-36.1%) in 2014, 35.6 (95%CI 35.0-36.2%) in 2015, and 35.6% (95%CI 35.0-36.2%) in 2018, respectively (p for development < 0.001).
Gene Knock-Out HR Targeting Vector [MCS1-EF1α-RFP-T2A-Puro-pA-MCS2] |
|||
HR110PA-1 | SBI | 10 ug | 933 EUR |
Gene Knock-Out HR Targeting Vector [MCS1-EF1a-GFP-T2A-Puro-pA-MCS2] |
|||
HR410PA-1 | SBI | 10 ug | 933 EUR |
Gene Knock-Out HR Targeting Vector [MCS1-EF1a-RFP-T2A-Hygro-pA-MCS2] |
|||
HR510PA-1 | SBI | 10 ug | 933 EUR |
B2M Knockout Jurkat Cell Line |
|||
78342 | BPS Bioscience | 2 vials | 6500 EUR |
Description: B2M (Beta-2-Microglobulin) has been genetically removed by CRISPR/Cas9 genome editing from Jurkat cells. |
|||
TCR Knockout Jurkat Cell Line |
|||
78539 | BPS Bioscience | 2 vials | 6500 EUR |
Description: The TCR Knockout Jurkat cell line was generated by CRISPR/Cas9 genome editing to remove the TRAC (T-Cell Receptor Alpha Constant) and TRBC1 (T-Cell Receptor Beta Constant 1) domains of the TCRα and β chains. |
|||
293AD Cell Line |
|||
AD-100 | Cell Biolabs | 1 vial | 553.2 EUR |
Description: The 293AD Cell Line is derived from the parental 293 cells but selected for attributes that increase adenovirus production, including firmer attachment and larger surface area. |
|||
B2M Knockout THP-1 Cell Line |
|||
78389 | BPS Bioscience | 2 vials | 6500 EUR |
Description: B2M (Beta-2-Microglobulin) has been genetically removed by CRISPR/Cas9 genome editing from THP-1 cells. |
|||
293AAV Cell Line |
|||
AAV-100 | Cell Biolabs | 1 vial | 609.6 EUR |
Description: The 293AAV Cell Line is derived from the parental 293 cells but selected for attributes that increase AAV production, including firmer attachment and larger surface area. |
|||
293LTV Cell Line |
|||
LTV-100 | Cell Biolabs | 1 vial | 609.6 EUR |
Description: The 293LTV Cell Line is derived from the parental 293 cells but selected for attributes that increase lentiviral production, including fimrer attachment and larger surface area. |
|||
293RTV Cell Line |
|||
RV-100 | Cell Biolabs | 1 vial | 609.6 EUR |
Description: The 293RTV Cell Line is derived from the parental 293 cells but selected for attributes that increase retroviral production, including fimrer attachment and larger surface area. |
|||
Basic HR Targeting Vector [MCS1-LoxP-MCS2-MCS3-pA-LoxP-MCS4] for Gene Knock-In/Out |
|||
HR100PA-1 | SBI | 10 ug | 868 EUR |
Rrad 3'UTR Luciferase Stable Cell Line |
|||
TU118183 | ABM | 1.0 ml | Ask for price |
RRAD 3'UTR Luciferase Stable Cell Line |
|||
TU022380 | ABM | 1.0 ml | 1672.8 EUR |
Rrad 3'UTR Luciferase Stable Cell Line |
|||
TU219725 | ABM | 1.0 ml | Ask for price |
CIITA Knockout THP-1 Cell Line |
|||
78390 | BPS Bioscience | 2 vials | 6500 EUR |
Description: CIITA (Class II Transactivator) has been genetically removed from THP-1 cells using CRISPR/Cas9 genome editing. |
|||
TCR/B2M Knockout Jurkat Cell Line |
|||
78552 | BPS Bioscience | 2 vials | 8645 EUR |
Description: This cell line is a double knockout of TCR (T Cell Receptor) and B2M (Beta-2-Microglobulin). First, the TRAC (T-Cell Receptor Alpha Constant) and the TRBC1 (T-Cell Receptor Beta Constant 1) domains of the TCRα/β chains were genetically removed by CRISPR/Cas9 genome editing from Jurkat cells to generate the TCR Knockout Jurkat cell Line (BPS Bioscience #78539). These TCR knockout cells were then used to generate a new cell line in which B2M was also genetically removed by CRISPR/Cas9 genome editing. |
|||
293/GFP Cell Line |
|||
AKR-200 | Cell Biolabs | 1 vial | 686.4 EUR |
Description: 293/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line. |
|||
T47D/GFP Cell Line |
|||
AKR-208 | Cell Biolabs | 1 vial | 686.4 EUR |
Description: T47D/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line. |
|||
A549/GFP Cell Line |
|||
AKR-209 | Cell Biolabs | 1 vial | 686.4 EUR |
Description: A549/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line. |
|||
HeLa/GFP Cell Line |
|||
AKR-213 | Cell Biolabs | 1 vial | 686.4 EUR |
Description: HeLa/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line. |
|||
293/Cas9 Cell Line |
|||
AKR-5110 | Cell Biolabs | 1 vial | 686.4 EUR |
HeLa/Cas9 Cell Line |
|||
AKR-5111 | Cell Biolabs | 1 vial | 686.4 EUR |
NIH3T3/GFP Cell Line |
|||
AKR-214 | Cell Biolabs | 1 vial | 686.4 EUR |
Description: NIH3T3/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line. |
|||
NIH3T3/Cas9 Cell Line |
|||
AKR-5104 | Cell Biolabs | 1 vial | 686.4 EUR |
Human K562 Whole Cell Lysate |
|||
LYSATE0031 | BosterBio | 200ug | 180 EUR |
Description: This cell lysate is prepared from human K562 using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
|||
TARGATT? Knock-in iPSC Quick Knockin Kit |
|||
AST-1101 | Applied StemCell | 1 Kit | Ask for price |
Description: 12 month |
|||
FCGR2A (CD32A) Knockout Jurkat Cell Line |
|||
78549 | BPS Bioscience | 2 vials | 6500 EUR |
Description: The FCGR2A Knockout Jurkat cell line was generated by CRISPR/Cas9 genome editing to remove FCGR2A (CD32A), the gene encoding protein FcγRIIa (Fragment crystallizable gamma receptor II a, also known as FcGRIIa, Fc-gamma-RIIa, and CD32A). |
|||
MCF-7/Luc Cell Line |
|||
AKR-234 | Cell Biolabs | 1 vial | 686.4 EUR |
Description: MCF-7/Luc Cell Line stably expresses luciferase and otherwise exhibits the same characteristics of the parental cell line. |
|||
SKOV-3/Luc Cell Line |
|||
AKR-232 | Cell Biolabs | 1 vial | 686.4 EUR |
Description: SKOV-3/Luc Cell Line stably expresses luciferase and otherwise exhibits the same characteristics of the parental cell line. |
|||
OVCAR-5/RFP Cell Line |
|||
AKR-254 | Cell Biolabs | 1 vial | 686.4 EUR |
Description: OVCAR-5/RFP Cell Line stably expresses RFP and otherwise exhibits the same characteristics of the parental cell line. |
|||
B2M/CIITA Double Knockout THP-1 Cell Line |
|||
78391 | BPS Bioscience | 2 vials | 9500 EUR |
Description: Both B2M (Beta-2-Microglobulin) and CIITA (Class II Transactivator) have been genetically removed from THP-1 cells using CRISPR/Cas9 genome editing. |
|||
RRAD sgRNA CRISPR Lentivector set (Human) |
|||
K2069901 | ABM | 3 x 1.0 ug | 406.8 EUR |
TARGATT? Knock-in iPSC Genotyping Kit |
|||
AST-1102 | Applied StemCell | 1 Kit | Ask for price |
Description: 12 month |
|||
Platinum-E Retroviral Packaging Cell Line, Ecotropic |
|||
RV-101 | Cell Biolabs | 1 vial | 1104 EUR |
Description: Conventional cells used for retrovirus packaging, such as those based on NIH3T3 cells, have limited stability and produce relatively low yields of retrovirus, mainly due to the poor expression of retroviral structure proteins (gag, pol and env) in the cells. The Platinum Retroviral Packaging Cell Lines are based on the 293T cell line. They exhibit longer stability and produce higher yields of retroviral structure proteins. Plat-E cells contain gag, pol and env genes, allowing retroviral packaging with a single plasmid transfection. |
|||
Platinum-GP Retroviral Packaging Cell Line, Pantropic |
|||
RV-103 | Cell Biolabs | 1 vial | 1104 EUR |
Description: Conventional cells used for retrovirus packaging, such as those based on NIH3T3 cells, have limited stability and produce relatively low yields of retrovirus, mainly due to the poor expression of retroviral structure proteins (gag, pol and env) in the cells. The Platinum Retroviral Packaging Cell Lines are based on the 293T cell line. They exhibit longer stability and produce higher yields of retroviral structure proteins. Plat-GP cells contain the gag and pol genes required for retroviral packaging; an expression vector is co-transfected with a VSVG envelope vector. |
|||
Platinum-A Retroviral Packaging Cell Line, Amphotropic |
|||
RV-102 | Cell Biolabs | 1 vial | 1104 EUR |
Description: Conventional cells used for retrovirus packaging, such as those based on NIH3T3 cells, have limited stability and produce relatively low yields of retrovirus, mainly due to the poor expression of retroviral structure proteins (gag, pol and env) in the cells. The Platinum Retroviral Packaging Cell Lines are based on the 293T cell line. They exhibit longer stability and produce higher yields of retroviral structure proteins. Plat-A cells contain gag, pol and env genes, allowing retroviral packaging with a single plasmid transfection. |
|||
Total Protein - Murine Embryonic Stem Cell Line D3 |
|||
CBA-305 | Cell Biolabs | 500 ?g | 414 EUR |
Description:
|
|||
B2M Knockout NFAT Luciferase Reporter Jurkat Cell Line |
|||
78363 | BPS Bioscience | 2 vials | 11095 EUR |
Description: B2M (Beta-2-Microglobulin) has been genetically removed by CRISPR/Cas9 genome editing from NFAT Luciferase Reporter Jurkat cells. Expression of the firefly luciferase gene is driven by NFAT response elements located upstream of the minimal TATA promoter. Activation of the NFAT signaling pathway in these cells can be monitored by measuring luciferase activity. |
|||
TCR Knockout NFAT-Luciferase Reporter Jurkat Cell Line |
|||
78556 | BPS Bioscience | 2 vials | 12205 EUR |
Description: This cell line is a knockout of TCR (T Cell Receptor). The TRAC (T-Cell Receptor Alpha Constant) and TRBC1 (T-Cell Receptor Beta Constant 1) domains of the TCRα/β chains were genetically removed by CRISPR/Cas9 genome editing from recombinant Jurkat cells stably expressing the firefly luciferase gene under the control of NFAT response elements.This cell line has been functionally validated and does not respond to anti-CD3 agonist antibodies, as opposed to parental NFAT-Luciferase Reporter Jurkat cells (BPS Bioscience #60621). |
|||
K562 cells |
|||
C0003004 | Addexbio | One Frozen vial | 546 EUR |
TCR/B2M Knockout NFAT Luciferase Reporter Jurkat Cell Line |
|||
78557 | BPS Bioscience | 2 vials | 16695 EUR |
Description: This cell line is a double knockout of TCR (T Cell Receptor) and B2M (Beta-2-Microglobulin). First, the TRAC (T-Cell Receptor Alpha Constant) and the TRBC1 (T-Cell Receptor Beta Constant 1) domains of the TCRα/β chains were genetically removed by CRISPR/Cas9 genome editing from NFAT Luciferase Reporter Jurkat cells to generate the TCR Knockout NFAT Luciferase Reporter Jurkat cell Line (BPS Bioscience #78556). These TCR knockout cells were used to generate a new cell line in which B2M was also genetically removed by CRISPR/Cas9 genome editing. _x000D_Expression of the firefly luciferase gene is driven by NFAT response elements located upstream of the minimal TATA promoter. Activation of the NFAT signaling pathway in these cells can be monitored by measuring luciferase activity. |
|||
RRAD sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
K2069902 | ABM | 1.0 ug DNA | 184.8 EUR |
RRAD sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
K2069903 | ABM | 1.0 ug DNA | 184.8 EUR |
RRAD sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
K2069904 | ABM | 1.0 ug DNA | 184.8 EUR |
Gene Knock-Out HR Targeting Vector w/Single Selection Marker (Blasticidin) and Negative Selection (TK) Against Random Integration |
|||
HR720PA-1 | SBI | 10 µg | 1071 EUR |
Gene Knock-Out HR Targeting Vector w/Dual Selection Markers (GFP+Puro) and Negative Selection (TK) Against Random Integration |
|||
HR700PA-1 | SBI | 10 µg | 1071 EUR |
Gene Knock-Out HR Targeting Vector w/Dual Selection Markers (RFP+Hygro) and Negative Selection (TK) Against Random Integration |
|||
HR710PA-1 | SBI | 10 µg | 1071 EUR |
Gene Knock-Out HR Targeting Vector with TK selection [MCS1-LoxP-EF1α-GFP-T2A-Puro-P2A-hsvTK-pA-LoxP-MCS2] |
|||
HR210PA-1 | SBI | 10 ug | 1071 EUR |
Rrad/ Rat Rrad ELISA Kit |
|||
ELI-14921r | Lifescience Market | 96 Tests | 1063.2 EUR |
RRAD ELISA KIT|Human |
|||
EF005507 | Lifescience Market | 96 Tests | 826.8 EUR |
Rrad sgRNA CRISPR Lentivector set (Rat) |
|||
K7052701 | ABM | 3 x 1.0 ug | 406.8 EUR |
Human RRAD shRNA Plasmid |
|||
20-abx954199 | Abbexa |
|
|
Rrad sgRNA CRISPR Lentivector set (Mouse) |
|||
K3480701 | ABM | 3 x 1.0 ug | 406.8 EUR |
RRAD sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
K2069905 | ABM | 3 x 1.0 ug | 451.2 EUR |
RRAD Recombinant Protein (Human) |
|||
RP095493 | ABM | 100 ug | Ask for price |
RRAD sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
|||
K2069906 | ABM | 1.0 ug DNA | 200.4 EUR |
RRAD sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
|||
K2069907 | ABM | 1.0 ug DNA | 200.4 EUR |
RRAD sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
|||
K2069908 | ABM | 1.0 ug DNA | 200.4 EUR |
Rrad sgRNA CRISPR Lentivector (Rat) (Target 1) |
|||
K7052702 | ABM | 1.0 ug DNA | 184.8 EUR |
Rrad sgRNA CRISPR Lentivector (Rat) (Target 2) |
|||
K7052703 | ABM | 1.0 ug DNA | 184.8 EUR |
Rrad sgRNA CRISPR Lentivector (Rat) (Target 3) |
|||
K7052704 | ABM | 1.0 ug DNA | 184.8 EUR |
RRAD ORF Vector (Human) (pORF) |
|||
ORF031832 | ABM | 1.0 ug DNA | 486 EUR |
Rrad sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
K3480702 | ABM | 1.0 ug DNA | 184.8 EUR |
Rrad sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
K3480703 | ABM | 1.0 ug DNA | 184.8 EUR |
Rrad sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
K3480704 | ABM | 1.0 ug DNA | 184.8 EUR |
RRAD siRNA |
|||
20-abx932133 | Abbexa |
|
|
RRAD Peptide |
|||
43-008P | ProSci | 0.1 mg | 405.6 EUR |
Description: RRAD Peptide |
|||
RRAD Antibody |
|||
37229-100ul | SAB | 100ul | 302.4 EUR |
RRAD antibody |
|||
70R-5797 | Fitzgerald | 50 ug | 560.4 EUR |
Description: Rabbit polyclonal RRAD antibody raised against the middle region of RRAD |
|||
RRAD antibody |
|||
70R-5798 | Fitzgerald | 50 ug | 560.4 EUR |
Description: Rabbit polyclonal RRAD antibody raised against the middle region of RRAD |
|||
RRAD antibody |
|||
70R-50359 | Fitzgerald | 100 ul | 292.8 EUR |
Description: Purified Polyclonal RRAD antibody |
|||
RRAD Antibody |
|||
1-CSB-PA003910 | Cusabio |
|
|
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human. This antibody is Unconjugated. Tested in the following application: WB, IHC, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/20000 |
|||
RRAD Antibody |
|||
CSB-PA233809- | Cusabio | each | 402 EUR |
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:3000, IHC:1:50-1:100, IF:1:100-1:500 |
|||
RRAD Antibody |
|||
CSB-PA233809-100ul | Cusabio | 100ul | 379.2 EUR |
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:3000, IHC:1:50-1:100, IF:1:100-1:500 |
|||
RRAD Antibody |
|||
1-CSB-PA248209 | Cusabio |
|
|
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:5000, IHC:1:25-1:100 |
|||
RRAD Antibody |
|||
1-CSB-PA779820 | Cusabio |
|
|
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200 |
|||
RRAD Antibody |
|||
R34275-100UG | NSJ Bioreagents | 100 ug | 339.15 EUR |
Description: Additional name(s) for this target protein: Ras-related associated with diabetes |
|||
hspCas9 AAVS1 Safe Harbor Knock-in Donor (AAVS1-SA-puro-EF1-hspCas9) |
|||
CAS620A-1 | SBI | 10 ug | 1106 EUR |
CytoSelect Cell Transformation Assay (Cell Recovery Compatible), Colorimetric |
|||
CBA-135 | Cell Biolabs | 96 assays | 985.2 EUR |
Description: CytoSelect 96-Well Cell Transformation Assays (Cell Recovery Compatible) provide a robust system for detecting transformed cells, screening cell transformation inhibitors, and determining in vitro drug sensitivity. A proprietary modified soft agar matrix allows you to either quantify cells using the included fluorescent dye, or recover the cells for further analysis. |
|||
CytoSelect Cell Transformation Assay (Cell Recovery Compatible), Colorimetric |
|||
CBA-135-5 | Cell Biolabs | 5 x 96 assays | 4027.2 EUR |
Description: CytoSelect 96-Well Cell Transformation Assays (Cell Recovery Compatible) provide a robust system for detecting transformed cells, screening cell transformation inhibitors, and determining in vitro drug sensitivity. A proprietary modified soft agar matrix allows you to either quantify cells using the included fluorescent dye, or recover the cells for further analysis. |
|||
CytoSelect Cell Transformation Assay (Cell Recovery Compatible), Fluorometric |
|||
CBA-140 | Cell Biolabs | 96 assays | 1027.2 EUR |
Description: CytoSelect 96-Well Cell Transformation Assays (Cell Recovery Compatible) provide a robust system for detecting transformed cells, screening cell transformation inhibitors, and determining in vitro drug sensitivity. A proprietary modified soft agar matrix allows you to either quantify cells using the included fluorescent dye, or recover the cells for further analysis. |
|||
CytoSelect Cell Transformation Assay (Cell Recovery Compatible), Fluorometric |
|||
CBA-140-5 | Cell Biolabs | 5 x 96 assays | 4179.6 EUR |
Description: CytoSelect 96-Well Cell Transformation Assays (Cell Recovery Compatible) provide a robust system for detecting transformed cells, screening cell transformation inhibitors, and determining in vitro drug sensitivity. A proprietary modified soft agar matrix allows you to either quantify cells using the included fluorescent dye, or recover the cells for further analysis. |
|||
StemTAG Stem Cell Colony Formation Assay (Cell Recovery Compatible) |
|||
CBA-325 | Cell Biolabs | 96 assays | 1027.2 EUR |
Description: Our StemTAG 96-Well Stem Cell Colony Formation Assay provides a high-throughput method to quantify ES cells in just 7-10 days, and no manual cell counting is required. Once colonies are formed, they may be analyzed in three different ways: 1. Lyse cells, then quantify in a fluorescence plate reader using dye included in the kit; 2. Lyse cells, then quantify alkaline phosphatase activity using reagents provided; or 3. Recover colonies from matrix for further culture or analysis. |
|||
StemTAG Stem Cell Colony Formation Assay (Cell Recovery Compatible) |
|||
CBA-325-5 | Cell Biolabs | 5 x 96 assays | 4033.2 EUR |
Description: Our StemTAG 96-Well Stem Cell Colony Formation Assay provides a high-throughput method to quantify ES cells in just 7-10 days, and no manual cell counting is required. Once colonies are formed, they may be analyzed in three different ways: 1. Lyse cells, then quantify in a fluorescence plate reader using dye included in the kit; 2. Lyse cells, then quantify alkaline phosphatase activity using reagents provided; or 3. Recover colonies from matrix for further culture or analysis. |
|||
CytoSelect Cell Transformation Assay (Cell Recovery Compatible), Colorimetric, Trial Size |
|||
CBA-135-T | Cell Biolabs | 24 assays | 518.4 EUR |
Description: CytoSelect 96-Well Cell Transformation Assays (Cell Recovery Compatible) provide a robust system for detecting transformed cells, screening cell transformation inhibitors, and determining in vitro drug sensitivity. A proprietary modified soft agar matrix allows you to either quantify cells using the included fluorescent dye, or recover the cells for further analysis. |
|||
CytoSelect 96-Well Cell Transformation Assay (Cell Recovery Compatible, Fluorometric), Trial Size |
|||
CBA-140-T | Cell Biolabs | 24 assays | 547.2 EUR |
Description: CytoSelect 96-Well Cell Transformation Assays (Cell Recovery Compatible) provide a robust system for detecting transformed cells, screening cell transformation inhibitors, and determining in vitro drug sensitivity. A proprietary modified soft agar matrix allows you to either quantify cells using the included fluorescent dye, or recover the cells for further analysis. |
|||
K562 Nuclear Extract |
|||
X12005 | EpiGentek | 1000 µg | Ask for price |
K562 Membrane Lysate |
|||
XBL-10441 | ProSci | 0.1 mg | 619.8 EUR |
Description: K562 (Human Chronic Myelogenous Leukemia; Bone Marrow) cell membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The K562 (Human Chronic Myelogenous Leukemia; Bone Marrow) cell was frozen in liquid nitrogen immediately after excision and then stored at -70ºC. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated K562 (Human Chronic Myelogenous Leukemia; Bone Marrow) cell membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated K562 (Human Chronic Myelogenous Leukemia; Bone Marrow) cell membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
|||
K562 Cytoplasmic Lysate |
|||
XBL-10447 | ProSci | 0.1 mg | 273.3 EUR |
Description: K562 (Human Chronic Myelogenous Leukemia; Bone Marrow) Cell cytoplasmic Protein Lysate cytoplasmic protein lysate was prepared by isolating the cytoplasmic protein from whole tissue homogenates using a proprietary technique. The cytoplasmic protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, glycerol, and a cocktail of protease inhibitors. For quality control purposes, the isolated K562 (Human Chronic Myelogenous Leukemia; Bone Marrow) cytoplasmic protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated K562 (Human Chronic Myelogenous Leukemia; Bone Marrow) tissue cytoplasmic protein is then Western analyzed by GAPDH antibody, and the expression level is consistent with each lot. |
|||
Cas9 (CRISPR Associated Protein 9) ELISA Kit |
|||
PRB-5079 | Cell Biolabs | 96 assays | 686.4 EUR |
Collagen-based Cell Contraction Assay |
|||
CBA-201 | Cell Biolabs | 24 assays | 582 EUR |
Description: Cell Biolabs? Collagen-based Contraction Assay Kit provides a simple system to assess cell contractivity in vitro and screen cell contraction mediators. Each kit provides sufficient quantities to perform up to 24 assays in a 24-well plate. The kit can be also used in culturing cells in 3D collagen matrix. |
|||
CytoSelect MTT Cell Proliferation Assay |
|||
CBA-252 | Cell Biolabs | 960 assays | 490.8 EUR |
Description: Cell Biolabs? CytoSelect MTT Cell Proliferation Assay provides a colorimetric format for measuring and monitoring cell proliferation. The kit contains sufficient reagents for the evaluation of 960 assays in 96-well plates or 192 assays in 24-well plates. Cells can be plated and then treated with compounds or agents that affect proliferation. Cells are then detected with the proliferation reagent, which is converted in live cells from the yellow tetrazole MTT to the purple formazan form by a cellular reductase (Figure 1). An increase in cell proliferation is accompanied by an increased signal, while a decrease in cell proliferation (and signal) can indicate the toxic effects of compounds or suboptimal culture conditions. The assay principles are basic and can be applied to most eukaryotic cell lines, including adherent and non-adherent cells and certain tissues. This cell proliferation reagent can be used to detect proliferation in bacteria, yeast, fungi, protozoa as well as cultured mammalian and piscine cells. |
|||
Human K562 (Chronic Myelogenous Leukemia) lysate |
|||
HCL-1204 | Alpha Diagnostics | 1 mg | 628.8 EUR |
Radius 24-Well Cell Migration Assay |
|||
CBA-125 | Cell Biolabs | 24 assays | 602.4 EUR |
Description: The Radius Cell Migration Assay provides a unique alternative to conventional cell migration assays using the Boyden chamber. Unlike Boyden chamber assays which may only be analyzed at endpoint, the Radius assay uses a proprietary cell culture plate containing a carefully-defined biocompatible hydrogel (Radius gel) spot centralized at the bottom of each well. When cells are seeded in the well, they will attach everywhere except on the Radius gel, creating a cell-free zone. Following cell seeding the Radius gel is removed, allowing migratory cells to move across the area and close the gap. |
|||
Radius 24-Well Cell Migration Assay |
|||
CBA-125-5 | Cell Biolabs | 5 x 24 assays | 2362.8 EUR |
Description: The Radius Cell Migration Assay provides a unique alternative to conventional cell migration assays using the Boyden chamber. Unlike Boyden chamber assays which may only be analyzed at endpoint, the Radius assay uses a proprietary cell culture plate containing a carefully-defined biocompatible hydrogel (Radius gel) spot centralized at the bottom of each well. When cells are seeded in the well, they will attach everywhere except on the Radius gel, creating a cell-free zone. Following cell seeding the Radius gel is removed, allowing migratory cells to move across the area and close the gap. |
|||
Radius 96-Well Cell Migration Assay |
|||
CBA-126 | Cell Biolabs | 96 assays | 686.4 EUR |
Description: The Radius Cell Migration Assay provides a unique alternative to conventional cell migration assays using the Boyden chamber. Unlike Boyden chamber assays which may only be analyzed at endpoint, the Radius assay uses a proprietary cell culture plate containing a carefully-defined biocompatible hydrogel (Radius gel) spot centralized at the bottom of each well. When cells are seeded in the well, they will attach everywhere except on the Radius gel, creating a cell-free zone. Following cell seeding the Radius gel is removed, allowing migratory cells to move across the area and close the gap. |
|||
Radius 96-Well Cell Migration Assay |
|||
CBA-126-5 | Cell Biolabs | 5 x 96 assays | 2697.6 EUR |
Description: The Radius Cell Migration Assay provides a unique alternative to conventional cell migration assays using the Boyden chamber. Unlike Boyden chamber assays which may only be analyzed at endpoint, the Radius assay uses a proprietary cell culture plate containing a carefully-defined biocompatible hydrogel (Radius gel) spot centralized at the bottom of each well. When cells are seeded in the well, they will attach everywhere except on the Radius gel, creating a cell-free zone. Following cell seeding the Radius gel is removed, allowing migratory cells to move across the area and close the gap. |
|||
Radius 384-Well Cell Migration Assay |
|||
CBA-127 | Cell Biolabs | 384 assays | 721.2 EUR |
Description: The Radius Cell Migration Assay provides a unique alternative to conventional cell migration assays using the Boyden chamber. Unlike Boyden chamber assays which may only be analyzed at endpoint, the Radius assay uses a proprietary cell culture plate containing a carefully-defined biocompatible hydrogel (Radius gel) spot centralized at the bottom of each well. When cells are seeded in the well, they will attach everywhere except on the Radius gel, creating a cell-free zone. Following cell seeding the Radius gel is removed, allowing migratory cells to move across the area and close the gap. |
|||
Radius 384-Well Cell Migration Assay |
|||
CBA-127-5 | Cell Biolabs | 5 x 384 wells | 2802 EUR |
Description: The Radius Cell Migration Assay provides a unique alternative to conventional cell migration assays using the Boyden chamber. Unlike Boyden chamber assays which may only be analyzed at endpoint, the Radius assay uses a proprietary cell culture plate containing a carefully-defined biocompatible hydrogel (Radius gel) spot centralized at the bottom of each well. When cells are seeded in the well, they will attach everywhere except on the Radius gel, creating a cell-free zone. Following cell seeding the Radius gel is removed, allowing migratory cells to move across the area and close the gap. |
|||
Radius 48-Well Cell Migration Assay |
|||
CBA-5037 | Cell Biolabs | 48 assays | 622.8 EUR |
Description: The Radius Cell Migration Assay provides a unique alternative to conventional cell migration assays using the Boyden chamber. Unlike Boyden chamber assays which may only be analyzed at endpoint, the Radius assay uses a proprietary cell culture plate containing a carefully-defined biocompatible hydrogel (Radius gel) spot centralized at the bottom of each well. When cells are seeded in the well, they will attach everywhere except on the Radius gel, creating a cell-free zone. Following cell seeding the Radius gel is removed, allowing migratory cells to move across the area and close the gap. |
|||
Radius 48-Well Cell Migration Assay |
|||
CBA-5037-5 | Cell Biolabs | 5 x 48 assays | 2454 EUR |
Description: The Radius Cell Migration Assay provides a unique alternative to conventional cell migration assays using the Boyden chamber. Unlike Boyden chamber assays which may only be analyzed at endpoint, the Radius assay uses a proprietary cell culture plate containing a carefully-defined biocompatible hydrogel (Radius gel) spot centralized at the bottom of each well. When cells are seeded in the well, they will attach everywhere except on the Radius gel, creating a cell-free zone. Following cell seeding the Radius gel is removed, allowing migratory cells to move across the area and close the gap. |
|||
HIF-1 Alpha Cell Based ELISA Kit |
|||
CBA-281 | Cell Biolabs | 96 assays | 734.4 EUR |
Description: Cell Biolabs? HIF-1 Cell Based ELISA Kit is an immunoassay developed for rapid detection of HIF-1 Alpha in fixed cells. Cells on a microplate are stimulated for HIF-1 Alpha stabilization, fixed, permeabilized, and then neutralized in the well. HIF-1 Alpha is then detected with an anti-HIF-1 alpha antibody followed by an HRP conjugated secondary antibody. Each kit provides sufficient reagents to perform up to a total of 96 assays and can detect HIF-1 Alpha from human, mouse, or rat. |
|||
Cas13a (CRISPR Associated Protein 13a, C2c2) ELISA Kit |
|||
PRB-5091 | Cell Biolabs | 96 assays | 686.4 EUR |
CytoSelect BrdU Cell Proliferation ELISA Kit |
|||
CBA-251 | Cell Biolabs | 96 assays | 637.2 EUR |
Description: The CytoSelect BrdU Cell Proliferation ELISA Kit detects BrdU incorporated into cellular DNA during cell proliferation using an anti-BrdU antibody. When cells are incubated in media containing BrdU, the pyrimidine analog is incorporated in place of thymidine into the newly synthesized DNA of proliferating cells. Once the labeling media is removed, the cells are fixed and the DNA is denatured in one step with a fix/denature solution (denaturation of the DNA is necessary to improve the accessibility of the incorporated BrdU for detection). Then an anti-BrdU mouse monoclonal antibody is added followed by an HRP conjugated secondary antibody to detect the incorporated BrdU. The magnitude of the absorbance for the developed color is proportional to the quantity of BrdU incorporated into cells and can be directly correlated to cell proliferation. |
|||
CytoSelect 96-well Cell Transformation Assay |
|||
CBA-130 | Cell Biolabs | 96 assays | 866.4 EUR |
Description: Our CytoSelect 96-Well Cell Transformation Assay (Soft Agar Colony Formation) is suitable for measuring cell transformation where no downstream analysis is required. Cells are incubated in a semisolid agar medium for 7-8 days. The cells are then solubilized, lysed and detected using the included fluorescent dye in a fluorometric plate reader. |
|||
CytoSelect 96-well Cell Transformation Assay |
|||
CBA-130-5 | Cell Biolabs | 5 x 96 assays | 3463.2 EUR |
Description: Our CytoSelect 96-Well Cell Transformation Assay (Soft Agar Colony Formation) is suitable for measuring cell transformation where no downstream analysis is required. Cells are incubated in a semisolid agar medium for 7-8 days. The cells are then solubilized, lysed and detected using the included fluorescent dye in a fluorometric plate reader. |
|||
CytoSelect 24-well Cell Invasion, Fluorometric |
|||
CBA-111 | Cell Biolabs | 12 assays | 714 EUR |
Description: The ability of malignant tumor cells to invade normal surrounding tissue contributes in large part to the morbidity and mortality of cancers. Cell invasion requires several distinct cellular functions including adhesion, motility, detachment, and extracellular matrix proteolysis. Our CytoSelect Cell Invasion Assays utilize precoated inserts to assay the invasive properties of tumor cells. Invasive cells can be quantified in 24-well plates on either a standard microplate reader or a fluorescence plate reader. Inserts are precoated on the top of the membrane with ECM matrix gel (basement membrane), a protein mix isolated from EHS tumor cells. |
|||
CytoSelect 96-well Cell Invasion, Fluorometric |
|||
CBA-112 | Cell Biolabs | 96 assays | 908.4 EUR |
Description: The ability of malignant tumor cells to invade normal surrounding tissue contributes in large part to the morbidity and mortality of cancers. Cell invasion requires several distinct cellular functions including adhesion, motility, detachment, and extracellular matrix proteolysis. Our CytoSelect 96-Well Cell Invasion Assays utilize precoated inserts to assay the invasive properties of tumor cells. Invasive cells can be quantified in 96-well plates on a fluorescence plate reader. Inserts are precoated on the top of the membrane with Basement Membrane, an ECM protein mix isolated from EHS tumor cells. |
|||
CytoSelect Cell Viability and Cytotoxicity Assay |
|||
CBA-240 | Cell Biolabs | 96 assays | 470.4 EUR |
Description: The CytoSelect Cell Viability and Cytotoxicity Assay Kit provides a simple format for monitoring cell viability via metabolic activity. Live cells are detected with either MTT (colorimetric detection) or Calcein AM (fluorometric detection). Dead cells are detected by EthD-1 reagent (fluorometric). All 3 detection reagents are included, along with Saponin (a cell death initiator). Prior to the assay, cells may be treated with compounds or agents that affect cell viability. This kit is suitable for eukaryotic cells, not yeast or bacteria. |
|||
RRAD Blocking Peptide |
|||
20-abx063234 | Abbexa |
|
|
RRAD Blocking Peptide |
|||
33R-10070 | Fitzgerald | 100 ug | 216 EUR |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RRAD antibody, catalog no. 70R-5798 |
|||
RRAD Blocking Peptide |
|||
33R-4793 | Fitzgerald | 100 ug | 216 EUR |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RRAD antibody, catalog no. 70R-5797 |
|||
CytoSelect 24-Well Cell Co-Culture System |
|||
CBA-160 | Cell Biolabs | 24 assays | 525.6 EUR |
Description: CytoSelect 24-Well Cell Co-Culture System provides a unique platform to monitor direct contact between two cell types in a single well. First, cells are cultured until they form a monolayer around the insert, creating a defined 8 mm cell-free zone. Once the insert is removed, a second cell type may be seeded into the exposed zone. The kit contains proprietary treated inserts and sufficient reagents for the evaluation of 24 samples. The inserts are compatible with most adherent cell types and experimental conditions. |
|||
CytoSelect 24-Well Cell Co-Culture System |
|||
CBA-160-5 | Cell Biolabs | 5 x 24 assays | 2078.4 EUR |
Description: CytoSelect 24-Well Cell Co-Culture System provides a unique platform to monitor direct contact between two cell types in a single well. First, cells are cultured until they form a monolayer around the insert, creating a defined 8 mm cell-free zone. Once the insert is removed, a second cell type may be seeded into the exposed zone. The kit contains proprietary treated inserts and sufficient reagents for the evaluation of 24 samples. The inserts are compatible with most adherent cell types and experimental conditions. |
|||
RRAD Protein Vector (Human) (pPM-C-HA) |
|||
PV127328 | ABM | 500 ng | 662.4 EUR |
CytoSelect 48-Well Cell Contraction Assay Kit |
|||
CBA-5021 | Cell Biolabs | 48 assays | 762 EUR |
Description: Cell Biolabs? Cell Contraction Assays (Floating Matrix Model) provide a simple, in vitro system to assess cell contractivity and screen cell contraction mediators. The proprietary Cell Contraction Plate eliminates the matrix releasing step of the conventional contraction assay, providing a faster, higher-throughput method to assess cell contraction. |
|||
CytoSelect Cell Proliferation Assay Reagent (Fluorometric) |
|||
CBA-250 | Cell Biolabs | 10 mL | 490.8 EUR |
Description: Cell Biolabs? CytoSelect Cell Proliferation Assay Reagent (Fluorometric) provides a fluorometric format for measuring and monitoring cell proliferation. Cells can be plated and then treated with compounds or agents that affect proliferation. Cells are then incubated with the proliferation reagent. Upon entering metabolically active live cells, the non-fluorescent proliferation reagent is converted into a bright red fluorescent form. An increase in cell proliferation is accompanied by increased fluorescent signal, while a decrease in cell proliferation (and signal) can indicate the toxic effects of compounds or suboptimal culture conditions. The assay principles are basic and can be applied to most eukaryotic cell lines, including adherent and non-adherent cells and certain tissues. This cell proliferation reagent can be used to detect proliferation in bacteria, yeast, fungi, protozoa as well as cultured mammalian and piscine cells. The kit contains sufficient reagents for the evaluation of 960 assays in ten 96-well plates or 192 assays in eight 24-well plates. |
|||
CytoSelect Cell Proliferation Assay Reagent (Colorimetric) |
|||
CBA-253 | Cell Biolabs | 10 mL | 490.8 EUR |
Description: Cell Biolabs? CytoSelect WST-1 Cell Proliferation Assay Reagent provides a colorimetric format for measuring and monitoring cell proliferation. The 10 mL volume is sufficient for the evaluation of 960 assays in ten 96-well plates or 192 assays in eight 24-well plates. Cells can be plated and then treated with compounds or agents that affect proliferation. Cells are then detected with the proliferation reagent, which is converted in live cells from WST-1 to the formazan form in the presence of cellular NADH and an electron mediator. An increase in cell proliferation is accompanied by increased signal, while a decrease in cell proliferation (and signal) can indicate the toxic effects of compounds or suboptimal culture conditions. The assay principles are basic and can be applied to most eukaryotic cell lines, including adherent and non-adherent cells and certain tissues. This cell proliferation reagent can be used to detect proliferation in bacteria, yeast, fungi, protozoa as well as cultured mammalian and piscine cells. |
|||
Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) |
|||
K7052705 | ABM | 3 x 1.0 ug | 451.2 EUR |
AAVS1 Safe Harbor Targeting Vector 2.0 - GOI Knock-in Donor (AAVS1-SA-puro-EF1-MCS) |
|||
GE622A-1 | SBI | 10 ug | 1128 EUR |
RRAD Protein Vector (Human) (pPB-C-His) |
|||
PV127326 | ABM | 500 ng | 662.4 EUR |
RRAD Protein Vector (Human) (pPB-N-His) |
|||
PV127327 | ABM | 500 ng | 662.4 EUR |
RRAD Protein Vector (Human) (pPM-C-His) |
|||
PV127329 | ABM | 500 ng | 662.4 EUR |
CytoSelect 24-well Cell Invasion Assay, Colorimetric |
|||
CBA-110 | Cell Biolabs | 12 assays | 714 EUR |
Description: The ability of malignant tumor cells to invade normal surrounding tissue contributes in large part to the morbidity and mortality of cancers. Cell invasion requires several distinct cellular functions including adhesion, motility, detachment, and extracellular matrix proteolysis. Our CytoSelect Cell Invasion Assays utilize precoated inserts to assay the invasive properties of tumor cells. Invasive cells can be quantified in 24-well plates on either a standard microplate reader or a fluorescence plate reader. Inserts are precoated on the top of the membrane with ECM matrix gel (basement membrane), a protein mix isolated from EHS tumor cells. |
|||
CytoSelect 24-well Laminin Cell Invasion, Colorimetric |
|||
CBA-110-LN | Cell Biolabs | 12 assays | 714 EUR |
Description: The ability of malignant tumor cells to invade normal surrounding tissue contributes in large part to the morbidity and mortality of cancers. Cell invasion requires several distinct cellular functions including adhesion, motility, detachment, and extracellular matrix proteolysis. Our CytoSelect Cell Invasion Assays utilize precoated inserts to assay the invasive properties of tumor cells. Invasive cells can be quantified in 24-well plates on either a standard microplate reader or a fluorescence plate reader. Inserts are precoated on the top of the membrane with Laminin. |
|||
CytoSelect 24-well Collagen Cell Invasion, Colorimetric |
|||
CBA-110-COL | Cell Biolabs | 12 assays | 714 EUR |
Description: The ability of malignant tumor cells to invade normal surrounding tissue contributes in large part to the morbidity and mortality of cancers. Cell invasion requires several distinct cellular functions including adhesion, motility, detachment, and extracellular matrix proteolysis. Our CytoSelect Cell Invasion Assays utilize precoated inserts to assay the invasive properties of tumor cells. Invasive cells can be quantified in 24-well plates on either a standard microplate reader or a fluorescence plate reader. Inserts are precoated on the top of the membrane with Collagen I. |
|||
Polyclonal RRAD Antibody |
|||
APR05556G | Leading Biology | 0.1ml | 580.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human RRAD . This antibody is tested and proven to work in the following applications: |
|||
RRAD Conjugated Antibody |
|||
C37229 | SAB | 100ul | 476.4 EUR |
Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
|||
K3480705 | ABM | 3 x 1.0 ug | 451.2 EUR |
Radius 24-Well Cell Migration Assay, (Laminin Coated) |
|||
CBA-125-LN | Cell Biolabs | 24 assays | 714 EUR |
Description: The Radius Cell Migration Assay provides a unique alternative to conventional cell migration assays using the Boyden chamber. Unlike Boyden chamber assays which may only be analyzed at endpoint, the Radius assay uses a proprietary cell culture plate containing a carefully-defined biocompatible hydrogel (Radius gel) spot centralized at the bottom of each well. When cells are seeded in the well, they will attach everywhere except on the Radius gel, creating a cell-free zone. Following cell seeding the Radius gel is removed, allowing migratory cells to move across the area and close the gap. |
|||
CytoSelect 384-well Cell Transformation Assay, Fluorometric |
|||
CBA-145 | Cell Biolabs | 384 assays | 1208.4 EUR |
Description: Our CytoSelect 384-Well Cell Transformation Assay uses a modified soft agar 3D matrix to support the formation of colonies by neoplastic cells. Quantitation of cell transformation is performed on a fluorescence plate reader. |
|||
CytoSelect 384-well Cell Transformation Assay, Fluorometric |
|||
CBA-145-5 | Cell Biolabs | 5 x 384 assays | 4681.2 EUR |
Description: Our CytoSelect 384-Well Cell Transformation Assay uses a modified soft agar 3D matrix to support the formation of colonies by neoplastic cells. Quantitation of cell transformation is performed on a fluorescence plate reader. |
|||
StemTAG PCR Primer Set for Stem Cell Characterization |
|||
CBA-303 | Cell Biolabs | 1 kit | 470.4 EUR |
Description: StemTAG PCR Primer Set for Stem Cell Characterization includes 7 primer pairs: Oct-4, NANOG, AFP, Flk-1, and NCAM, plus GAPDH and beta-actin as controls. |
|||
CytoSelect 96-well Phagocytosis Assay (Red Blood Cell) |
|||
CBA-220 | Cell Biolabs | 96 assays | 762 EUR |
Description: Phagocytosis can be assayed by measuring the engulfment of a cell "substrate". However, traditional assays require tedious cell counting under a microscope. Our CytoSelect 96-Well Phagocytosis Assay, Red Blood Cell Substrate provides a more accurate, user-friendly, high-throughput alternative to the standard phagocytosis assay. The assay may be adapted for use with 24-well or 48-well plates. |
|||
CRISPR/Cas9 Kinase Knockout Lentivirus Library (Array Format) |
|||
78487 | BPS Bioscience | 200 µl x 649 | 7700 EUR |
Description: The CRISPR/Cas9 Kinase Knockout Lentivirus Library (Array Format) targets 619 human kinases and pseudo-kinases.bpsbioscience.com/media/wysiwyg/Kinases/Kinase_Library_-_List_Kinases_Pseudokinases_06-15-2022.xlsx Download the table to view all available kinases. The Array consists of a series of vials, with each vial containing a mixture of integrating CRISPR/Cas9 lentiviral particles targeting 5 sgRNAs for a specific gene (1 vial per gene, 5 sgRNAs per gene). The Array also includes a total of 150 control sgRNAs that do not target any gene (combined into 30 vials containing 5 control sgRNAs per vial). Thus, the Array contains a total of 649 vials and 3,245 sgRNAs.The lentiviruses are replication incompetent, VSV-G pseudotyped lentiviral particles ready to infect almost all types of mammalian cells, including primary and non-dividing cells. The SIN (self-inactivation) lentiviral backbone contains the Cas9 gene (Streptococcus pyogenes CRISPR associated protein 9) driven by an EF1a promoter, an sgRNA driven by a U6 promoter, and a puromycin selection marker.The lentiviruses integrate randomly into the cellular genome to express both Cas9 and the sgRNAs. Because the lentiviruses contain Cas9, they can be used in any target cell regardless of whether the cells already express Cas9. Puromycin selection ensures high expression of both Cas9 and the sgRNAs. Knockout efficiencies will depend on the cell type and the gene of interest. Stable CRISPR/Cas9 knockout cell lines can also be generated following limiting dilution.The library is delivered with a User Manual booklet. |
|||
CytoSelect Clonogenic Tumor Cell Isolation Kit (5 preps) |
|||
CBA-155 | Cell Biolabs | 5 preps | 957.6 EUR |
Description: Many solid tumors contain heterogeneous populations of normal and cancerous cells. Separation of these cell populations is key to an accurate assessment of the true genotypic and phenotypic differences between normal and tumor cells. Our CytoSelect Clonogenic Tumor Cell Isolation Kit uses a proprietary semisolid agar medium to facilitate formation of colonies by cells from solid tumors. Colonies are grown in either a 6-well plate or a 35mm culture dish. These colonies are isolated away from single (i.e. normal) cells by size filtration. The viable cells from these colonies can be easily recovered for further analysis. |
|||
Radius 24-Well Cell Migration Assay, (Fibronectin Coated) |
|||
CBA-125-FN | Cell Biolabs | 24 assays | 714 EUR |
Description: The Radius Cell Migration Assay provides a unique alternative to conventional cell migration assays using the Boyden chamber. Unlike Boyden chamber assays which may only be analyzed at endpoint, the Radius assay uses a proprietary cell culture plate containing a carefully-defined biocompatible hydrogel (Radius gel) spot centralized at the bottom of each well. When cells are seeded in the well, they will attach everywhere except on the Radius gel, creating a cell-free zone. Following cell seeding the Radius gel is removed, allowing migratory cells to move across the area and close the gap. |
|||
Radius 24-Well Cell Migration Assay, (ECM Array Coated) |
|||
CBA-125-ECM | Cell Biolabs | 24 wells | 838.8 EUR |
Description: The Radius Cell Migration Assay provides a unique alternative to conventional cell migration assays using the Boyden chamber. Unlike Boyden chamber assays which may only be analyzed at endpoint, the Radius assay uses a proprietary cell culture plate containing a carefully-defined biocompatible hydrogel (Radius gel) spot centralized at the bottom of each well. When cells are seeded in the well, they will attach everywhere except on the Radius gel, creating a cell-free zone. Following cell seeding the Radius gel is removed, allowing migratory cells to move across the area and close the gap. |
|||
CytoSelect Proliferating Cell Nuclear Antigen (PCNA) ELISA Kit |
|||
CBA-254 | Cell Biolabs | 96 assays | 672 EUR |
Description: Cell Biolabs? CytoSelect Proliferating Cell Nuclear Antigen (PCNA) ELISA Kit is an enzyme immunoassay developed for the detection and quantitation of PCNA from nuclear and whole cell extracts. The kit detects PCNA from mouse, rat and human, and has a detection sensitivity limit of 12.5 ng/mLPCNA. Each kit provides sufficient reagents to perform up to 96 assays including standard curve and unknown samples. |
|||
AAVS1 Safe Harbor Targeting Vector 2.0 - Reporter Knock-in Donor (AAVS1-SA-puro-MCS-GFP) |
|||
GE624A-1 | SBI | 10 ug | 1128 EUR |
CytoSelect 48-well Cell Adhesion Assay (Laminin, Colorimetric) |
|||
CBA-056 | Cell Biolabs | 48 assays | 512.4 EUR |
Description: Cell adhesion is a complex process involved in migration/invasion, embryogenesis, wound healing and tissue remodeling. Cells adhere to the extracellular matrix, forming complexes with cytoskeleton components that can affect cell motility, differentiation, proliferation, and survival. Our CytoSelect 48-Well Cell Adhesion Assays provide a fully quantitative method for the evaluation of cell adhesion. The 48-well plate is precoated with Laminin. |
|||
CytoSelect 48-well Cell Adhesion Assay (Laminin, Fluorometric) |
|||
CBA-057 | Cell Biolabs | 48 assays | 553.2 EUR |
Description: Cell adhesion is a complex process involved in migration/invasion, embryogenesis, wound healing and tissue remodeling. Cells adhere to the extracellular matrix, forming complexes with cytoskeleton components that can affect cell motility, differentiation, proliferation, and survival. Our CytoSelect 48-Well Cell Adhesion Assays provide a fully quantitative method for the evaluation of cell adhesion. The 48-well plate is precoated with Laminin. |
|||
CytoSelect 24-well Laminin Cell Invasion Assay, Fluorometric |
|||
CBA-111-LN | Cell Biolabs | 12 assays | 714 EUR |
Description: The ability of malignant tumor cells to invade normal surrounding tissue contributes in large part to the morbidity and mortality of cancers. Cell invasion requires several distinct cellular functions including adhesion, motility, detachment, and extracellular matrix proteolysis. Our CytoSelect Cell Invasion Assays utilize precoated inserts to assay the invasive properties of tumor cells. Invasive cells can be quantified in 24-well plates on either a standard microplate reader or a fluorescence plate reader. Inserts are precoated on the top of the membrane with Laminin. |
|||
CytoSelect 96-well Laminin Cell Invasion Assay, Fluorometric |
|||
CBA-112-LN | Cell Biolabs | 96 assays | 908.4 EUR |
Description: The ability of malignant tumor cells to invade normal surrounding tissue contributes in large part to the morbidity and mortality of cancers. Cell invasion requires several distinct cellular functions including adhesion, motility, detachment, and extracellular matrix proteolysis. Our CytoSelect 96-Well Cell Invasion Assays utilize precoated inserts to assay the invasive properties of tumor cells. Invasive cells can be quantified in 96-well plates on a fluorescence plate reader. Inserts are precoated on the top of the membrane with Laminin. |
|||
Radius 24-Well Cell Migration Assay, (Collagen I Coated) |
|||
CBA-125-COL | Cell Biolabs | 24 assays | 714 EUR |
Description: The Radius Cell Migration Assay provides a unique alternative to conventional cell migration assays using the Boyden chamber. Unlike Boyden chamber assays which may only be analyzed at endpoint, the Radius assay uses a proprietary cell culture plate containing a carefully-defined biocompatible hydrogel (Radius gel) spot centralized at the bottom of each well. When cells are seeded in the well, they will attach everywhere except on the Radius gel, creating a cell-free zone. Following cell seeding the Radius gel is removed, allowing migratory cells to move across the area and close the gap. |
|||
CytoSelect 24-well Collagen Cell Invasion Assay, Fluorometric |
|||
CBA-111-COL | Cell Biolabs | 12 assays | 714 EUR |
Description: The ability of malignant tumor cells to invade normal surrounding tissue contributes in large part to the morbidity and mortality of cancers. Cell invasion requires several distinct cellular functions including adhesion, motility, detachment, and extracellular matrix proteolysis. Our CytoSelect Cell Invasion Assays utilize precoated inserts to assay the invasive properties of tumor cells. Invasive cells can be quantified in 24-well plates on either a standard microplate reader or a fluorescence plate reader. Inserts are precoated on the top of the membrane with Collagen I. |
|||
CytoSelect 96-well Collagen Cell Invasion Assay, Fluorometric |
|||
CBA-112-COL | Cell Biolabs | 96 assays | 908.4 EUR |
Description: The ability of malignant tumor cells to invade normal surrounding tissue contributes in large part to the morbidity and mortality of cancers. Cell invasion requires several distinct cellular functions including adhesion, motility, detachment, and extracellular matrix proteolysis. Our CytoSelect 96-Well Cell Invasion Assays utilize precoated inserts to assay the invasive properties of tumor cells. Invasive cells can be quantified in 96-well plates on a fluorescence plate reader. Inserts are precoated on the top of the membrane with Collagen I. |
|||
CytoSelect 48-well Cell Adhesion Assay (Fibrinogen, Colorimetric) |
|||
CBA-058 | Cell Biolabs | 48 assays | 512.4 EUR |
Description: Cell adhesion is a complex process involved in migration/invasion, embryogenesis, wound healing and tissue remodeling. Cells adhere to the extracellular matrix, forming complexes with cytoskeleton components that can affect cell motility, differentiation, proliferation, and survival. Our CytoSelect 48-Well Cell Adhesion Assays provide a fully quantitative method for the evaluation of cell adhesion. The 48-well plate is precoated with Fibrinogen. |
|||
CytoSelect 48-well Cell Adhesion Assay (Fibrinogen, Fluorometric) |
|||
CBA-059 | Cell Biolabs | 48 assays | 553.2 EUR |
Description: Cell adhesion is a complex process involved in migration/invasion, embryogenesis, wound healing and tissue remodeling. Cells adhere to the extracellular matrix, forming complexes with cytoskeleton components that can affect cell motility, differentiation, proliferation, and survival. Our CytoSelect 48-Well Cell Adhesion Assays provide a fully quantitative method for the evaluation of cell adhesion. The 48-well plate is precoated with Fibrinogen. |
|||
CytoSelect 48-well Cell Adhesion Assay (Fibronectin, Colorimetric) |
|||
CBA-050 | Cell Biolabs | 48 assays | 512.4 EUR |
Description: Cell adhesion is a complex process involved in migration/invasion, embryogenesis, wound healing and tissue remodeling. Cells adhere to the extracellular matrix, forming complexes with cytoskeleton components that can affect cell motility, differentiation, proliferation, and survival. Our CytoSelect 48-Well Cell Adhesion Assays provide a fully quantitative method for the evaluation of cell adhesion. The 48-well plate is precoated with Fibronectin. |
|||
CytoSelect 48-well Cell Adhesion Assay (Fibronectin, Fluorometric) |
|||
CBA-051 | Cell Biolabs | 48 assays | 553.2 EUR |
Description: Cell adhesion is a complex process involved in migration/invasion, embryogenesis, wound healing and tissue remodeling. Cells adhere to the extracellular matrix, forming complexes with cytoskeleton components that can affect cell motility, differentiation, proliferation, and survival. Our CytoSelect 48-Well Cell Adhesion Assays provide a fully quantitative method for the evaluation of cell adhesion. The 48-well plate is precoated with Fibronectin. |
|||
CytoSelect 24-well Cell Migration Assay (8 ?m), Colorimetric |
|||
CBA-100 | Cell Biolabs | 12 assays | 651.6 EUR |
Description: Chemotaxis describes the movement of cells toward or away from a chemical stimulus in their environment. Cell chemotaxis plays a pivotal role in the progression of cancer and other diseases. CytoSelect Cell Migration Assays are ideal for determining the chemotactic properties of cells. The 8 µm pore size is suitable for most cell types including epithelial cells, fibroblasts, and cancer cell lines. |
|||
CytoSelect 24-well Cell Migration Assay (8 ?m), Colorimetric |
|||
CBA-100-5 | Cell Biolabs | 5 x 12 assays | 2745.6 EUR |
Description: Chemotaxis describes the movement of cells toward or away from a chemical stimulus in their environment. Cell chemotaxis plays a pivotal role in the progression of cancer and other diseases. CytoSelect Cell Migration Assays are ideal for determining the chemotactic properties of cells. The 8 µm pore size is suitable for most cell types including epithelial cells, fibroblasts, and cancer cell lines. |
|||
CytoSelect 24-well Cell Migration Assay (8 ?m), Fluorometric |
|||
CBA-101 | Cell Biolabs | 12 assays | 664.8 EUR |
Description: Chemotaxis describes the movement of cells toward or away from a chemical stimulus in their environment. Cell chemotaxis plays a pivotal role in the progression of cancer and other diseases. CytoSelect Cell Migration Assays are ideal for determining the chemotactic properties of cells. The 8 µm pore size is suitable for most cell types including epithelial cells, fibroblasts, and cancer cell lines. |
|||
CytoSelect 24-well Cell Migration Assay (8 ?m), Fluorometric |
|||
CBA-101-5 | Cell Biolabs | 5 x 12 assays | 2787.6 EUR |
Description: Chemotaxis describes the movement of cells toward or away from a chemical stimulus in their environment. Cell chemotaxis plays a pivotal role in the progression of cancer and other diseases. CytoSelect Cell Migration Assays are ideal for determining the chemotactic properties of cells. The 8 µm pore size is suitable for most cell types including epithelial cells, fibroblasts, and cancer cell lines. |
|||
CytoSelect 24-well Cell Migration Assay (5 ?m), Fluorometric |
|||
CBA-102 | Cell Biolabs | 12 assays | 664.8 EUR |
Description: Chemotaxis describes the movement of cells toward or away from a chemical stimulus in their environment. Cell chemotaxis plays a pivotal role in the progression of cancer and other diseases. CytoSelect Cell Migration Assays are ideal for determining the chemotactic properties of cells. The 5 µm pore size is ideal for monocytes / macrophages. |
|||
CytoSelect 24-well Cell Migration Assay (5 ?m), Fluorometric |
|||
CBA-102-5 | Cell Biolabs | 5 x 12 assays | 2787.6 EUR |
Description: Chemotaxis describes the movement of cells toward or away from a chemical stimulus in their environment. Cell chemotaxis plays a pivotal role in the progression of cancer and other diseases. CytoSelect Cell Migration Assays are ideal for determining the chemotactic properties of cells. The 5 µm pore size is ideal for monocytes / macrophages. |
|||
CytoSelect 24-well Cell Migration Assay (3 ?m), Fluorometric |
|||
CBA-103 | Cell Biolabs | 12 assays | 664.8 EUR |
Description: Chemotaxis describes the movement of cells toward or away from a chemical stimulus in their environment. Cell chemotaxis plays a pivotal role in the progression of cancer and other diseases. CytoSelect Cell Migration Assays are ideal for determining the chemotactic properties of cells. The 3 µm pore size is best for the smallest cells including neutrophils and other leukocytes. |
|||
CytoSelect 24-well Cell Migration Assay (3 ?m), Fluorometric |
|||
CBA-103-5 | Cell Biolabs | 5 x 12 assays | 2787.6 EUR |
Description: Chemotaxis describes the movement of cells toward or away from a chemical stimulus in their environment. Cell chemotaxis plays a pivotal role in the progression of cancer and other diseases. CytoSelect Cell Migration Assays are ideal for determining the chemotactic properties of cells. The 3 µm pore size is best for the smallest cells including neutrophils and other leukocytes. |
|||
CytoSelect 96-well Cell Migration Assay (3 ?m), Fluorometric |
|||
CBA-104 | Cell Biolabs | 96 assays | 762 EUR |
Description: Chemotaxis describes the movement of cells toward or away from a chemical stimulus in their environment. Cell chemotaxis plays a pivotal role in the progression of cancer and other diseases. CytoSelect Cell Migration Assays are ideal for determining the chemotactic properties of cells. The 3 µm pore size is best for the smallest cells including neutrophils and other leukocytes. |
|||
CytoSelect 96-well Cell Migration Assay (3 ?m), Fluorometric |
|||
CBA-104-5 | Cell Biolabs | 5 x 96 assays | 3135.6 EUR |
Description: Chemotaxis describes the movement of cells toward or away from a chemical stimulus in their environment. Cell chemotaxis plays a pivotal role in the progression of cancer and other diseases. CytoSelect Cell Migration Assays are ideal for determining the chemotactic properties of cells. The 3 µm pore size is best for the smallest cells including neutrophils and other leukocytes. |
|||
CytoSelect 96-well Cell Migration Assay (5 ?m), Fluorometric |
|||
CBA-105 | Cell Biolabs | 96 assays | 762 EUR |
Description: Chemotaxis describes the movement of cells toward or away from a chemical stimulus in their environment. Cell chemotaxis plays a pivotal role in the progression of cancer and other diseases. CytoSelect Cell Migration Assays are ideal for determining the chemotactic properties of cells. The 5 µm pore size is ideal for monocytes / macrophages. |
|||
CytoSelect 96-well Cell Migration Assay (5 ?m), Fluorometric |
|||
CBA-105-5 | Cell Biolabs | 5 x 96 assays | 3135.6 EUR |
Description: Chemotaxis describes the movement of cells toward or away from a chemical stimulus in their environment. Cell chemotaxis plays a pivotal role in the progression of cancer and other diseases. CytoSelect Cell Migration Assays are ideal for determining the chemotactic properties of cells. The 5 µm pore size is ideal for monocytes / macrophages. |
|||
CytoSelect 96-well Cell Migration Assay (8 ?m), Fluorometric |
|||
CBA-106 | Cell Biolabs | 96 assays | 762 EUR |
Description: Chemotaxis describes the movement of cells toward or away from a chemical stimulus in their environment. Cell chemotaxis plays a pivotal role in the progression of cancer and other diseases. CytoSelect Cell Migration Assays are ideal for determining the chemotactic properties of cells. The 8 µm pore size is suitable for most cell types including epithelial cells, fibroblasts, and cancer cell lines. |
|||
CytoSelect 96-well Cell Migration Assay (8 ?m), Fluorometric |
|||
CBA-106-5 | Cell Biolabs | 5 x 96 assays | 3135.6 EUR |
Description: Chemotaxis describes the movement of cells toward or away from a chemical stimulus in their environment. Cell chemotaxis plays a pivotal role in the progression of cancer and other diseases. CytoSelect Cell Migration Assays are ideal for determining the chemotactic properties of cells. The 8 µm pore size is suitable for most cell types including epithelial cells, fibroblasts, and cancer cell lines. |
|||
CytoSelect 24-well Cell Migration Assay (12 ?m), Colorimetric |
|||
CBA-107 | Cell Biolabs | 12 assays | 664.8 EUR |
Description: Chemotaxis describes the movement of cells toward or away from a chemical stimulus in their enviroment. Cell chemotaxis plays a pivotal role in the progression of cancer and other diseases. CytoSelect Cell Migration Assays are ideal for determining the chemotactic properties of cells. The 12 µm pore size is suitable for astrocytes and other large or slow-moving cells. |
|||
CytoSelect 24-well Cell Migration Assay (12 ?m), Fluorometric |
|||
CBA-108 | Cell Biolabs | 12 assays | 679.2 EUR |
Description: Chemotaxis describes the movement of cells toward or away from a chemical stimulus in their enviroment. Cell chemotaxis plays a pivotal role in the progression of cancer and other diseases. CytoSelect Cell Migration Assays are ideal for determining the chemotactic properties of cells. The 12 µm pore size is suitable for astrocytes and other large or slow-moving cells. |
|||
CytoSelect 48-well Cell Adhesion Assay (ECM Array, Colorimetric) |
|||
CBA-070 | Cell Biolabs | 48 assays | 699.6 EUR |
Description: Cell adhesion is a complex process involved in migration/invasion, embryogenesis, wound healing and tissue remodeling. Cells adhere to the extracellular matrix, forming complexes with cytoskeleton components that can affect cell motility, differentiation, proliferation, and survival. Our CytoSelect 48-Well Cell Adhesion Assays provide a fully quantitative method for the evaluation of cell adhesion. The 48-well plate is precoated with your choice of single ECM protein in each of the first 5 rows, with the last row provided as a negative control. |
|||
CytoSelect 48-well Cell Adhesion Assay (ECM Array, Colorimetric) |
|||
CBA-070-5 | Cell Biolabs | 5 x 48 assays | 2836.8 EUR |
Description: Cell adhesion is a complex process involved in migration/invasion, embryogenesis, wound healing and tissue remodeling. Cells adhere to the extracellular matrix, forming complexes with cytoskeleton components that can affect cell motility, differentiation, proliferation, and survival. Our CytoSelect 48-Well Cell Adhesion Assays provide a fully quantitative method for the evaluation of cell adhesion. The 48-well plate is precoated with your choice of single ECM protein in each of the first 5 rows, with the last row provided as a negative control. |
|||
CytoSelect 48-well Cell Adhesion Assay (ECM Array, Fluorometric) |
|||
CBA-071 | Cell Biolabs | 48 assays | 741.6 EUR |
Description: Cell adhesion is a complex process involved in migration/invasion, embryogenesis, wound healing and tissue remodeling. Cells adhere to the extracellular matrix, forming complexes with cytoskeleton components that can affect cell motility, differentiation, proliferation, and survival. Our CytoSelect 48-Well Cell Adhesion Assays provide a fully quantitative method for the evaluation of cell adhesion. The 48-well plate is precoated with your choice of single ECM protein in each of the first 5 rows, with the last row provided as a negative control. |
|||
CytoSelect 48-well Cell Adhesion Assay (ECM Array, Fluorometric) |
|||
CBA-071-5 | Cell Biolabs | 5 x 48 assays | 3045.6 EUR |
Description: Cell adhesion is a complex process involved in migration/invasion, embryogenesis, wound healing and tissue remodeling. Cells adhere to the extracellular matrix, forming complexes with cytoskeleton components that can affect cell motility, differentiation, proliferation, and survival. Our CytoSelect 48-Well Cell Adhesion Assays provide a fully quantitative method for the evaluation of cell adhesion. The 48-well plate is precoated with your choice of single ECM protein in each of the first 5 rows, with the last row provided as a negative control. |
|||
CytoSelect 48-well Cell Adhesion Assay (Collagen I, Colorimetric) |
|||
CBA-052 | Cell Biolabs | 48 assays | 512.4 EUR |
Description: Cell adhesion is a complex process involved in migration/invasion, embryogenesis, wound healing and tissue remodeling. Cells adhere to the extracellular matrix, forming complexes with cytoskeleton components that can affect cell motility, differentiation, proliferation, and survival. Our CytoSelect 48-Well Cell Adhesion Assays provide a fully quantitative method for the evaluation of cell adhesion. The 48-well plate is precoated with Collagen I. |
|||
CytoSelect 48-well Cell Adhesion Assay (Collagen I, Fluorometric) |
|||
CBA-053 | Cell Biolabs | 48 assays | 553.2 EUR |
Description: Cell adhesion is a complex process involved in migration/invasion, embryogenesis, wound healing and tissue remodeling. Cells adhere to the extracellular matrix, forming complexes with cytoskeleton components that can affect cell motility, differentiation, proliferation, and survival. Our CytoSelect 48-Well Cell Adhesion Assays provide a fully quantitative method for the evaluation of cell adhesion. The 48-well plate is precoated with Collagen I. |
|||
CytoSelect 48-well Cell Adhesion Assay (Collagen IV, Colorimetric) |
|||
CBA-060 | Cell Biolabs | 48 assays | 512.4 EUR |
Description: Cell adhesion is a complex process involved in migration/invasion, embryogenesis, wound healing and tissue remodeling. Cells adhere to the extracellular matrix, forming complexes with cytoskeleton components that can affect cell motility, differentiation, proliferation, and survival. Our CytoSelect 48-Well Cell Adhesion Assays provide a fully quantitative method for the evaluation of cell adhesion. The 48-well plate is precoated with Collagen IV. |
|||
CytoSelect 48-well Cell Adhesion Assay (Collagen IV, Fluorometric) |
|||
CBA-061 | Cell Biolabs | 48 assays | 553.2 EUR |
Description: Cell adhesion is a complex process involved in migration/invasion, embryogenesis, wound healing and tissue remodeling. Cells adhere to the extracellular matrix, forming complexes with cytoskeleton components that can affect cell motility, differentiation, proliferation, and survival. Our CytoSelect 48-Well Cell Adhesion Assays provide a fully quantitative method for the evaluation of cell adhesion. The 48-well plate is precoated with Collagen IV. |
|||
CytoSelect Clonogenic Tumor Cell Isolation Kit (5 x 5 preps) |
|||
CBA-155-5 | Cell Biolabs | 25 preps | 3894 EUR |
Description: Many solid tumors contain heterogeneous populations of normal and cancerous cells. Separation of these cell populations is key to an accurate assessment of the true genotypic and phenotypic differences between normal and tumor cells. Our CytoSelect Clonogenic Tumor Cell Isolation Kit uses a proprietary semisolid agar medium to facilitate formation of colonies by cells from solid tumors. Colonies are grown in either a 6-well plate or a 35mm culture dish. These colonies are isolated away from single (i.e. normal) cells by size filtration. The viable cells from these colonies can be easily recovered for further analysis. |
|||
CytoSelect 96-Well Hematopoietic Colony Forming Cell Assay (96 assays) |
|||
CBA-320 | Cell Biolabs | 96 assays | 644.4 EUR |
Description: Hematopoietic stem cells (HSCs) are well-characterized, tissue-specific stem cells that are responsible for the lifelong maintenance of the hematopoietic system. HSCs or hematopoietic progenitors known as colony-forming cells (CFCs) proliferate to form discrete colonies when cultured in a suitable 3D environment, such as methylcellulose supplemented with nutrients and cytokines. Our CytoSelect 96-Well Hematopoietic Colony Forming Cell Assay promotes the formation of HSC colonies in just 7-10 days. Cells can then be either quantified in a fluorescence plate reader or recovered from the semisolid medium for further downstream analysis. |
|||
CytoSelect 24-Well Cell Contraction Assay Kit (Floating Matrix Model) |
|||
CBA-5020 | Cell Biolabs | 24 assays | 679.2 EUR |
Description: Cell Biolabs? Cell Contraction Assays (Floating Matrix Model) provide a simple, in vitro system to assess cell contractivity and screen cell contraction mediators. The proprietary Cell Contraction Plate eliminates the matrix releasing step of the conventional contraction assay, providing a faster, higher-throughput method to assess cell contraction. |
|||
Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1) |
|||
K7052706 | ABM | 1.0 ug DNA | 200.4 EUR |
Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2) |
|||
K7052707 | ABM | 1.0 ug DNA | 200.4 EUR |
Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3) |
|||
K7052708 | ABM | 1.0 ug DNA | 200.4 EUR |
CytoSelect 24-well Cell Haptotaxis Assay (8 µm), FN-coated, Colorimetric |
|||
CBA-100-FN | Cell Biolabs | 12 assays | 679.2 EUR |
Description: Cell haptotaxis describes cell migration toward or along a gradient of chemoattractants or adhesion sites in the extracellular matrix. The CytoSelect Cell Haptotaxis Assays are ideal for determining the migratory properties of cells. The 8 µm membrane pore size is ideal for epithelial cells and fibroblasts. The membrane serves as a barrier to distinguish between migratory and non-migratory cells. |
|||
CytoSelect 24-well Cell Haptotaxis Assay (8 µm), FN-coated, Fluorometric |
|||
CBA-101-FN | Cell Biolabs | 12 assays | 714 EUR |
Description: Cell haptotaxis describes cell migration toward or along a gradient of chemoattractants or adhesion sites in the extracellular matrix. The CytoSelect Cell Haptotaxis Assays are ideal for determining the migratory properties of cells. The 8 µm membrane pore size is ideal for epithelial cells and fibroblasts. The membrane serves as a barrier to distinguish between migratory and non-migratory cells. |
|||
CytoSelect 24-well Cell Haptotaxis Assay (8 µm), COL-coated, Colorimetric |
|||
CBA-100-COL | Cell Biolabs | 12 assays | 679.2 EUR |
Description: Cell haptotaxis describes cell migration toward or along a gradient of chemoattractants or adhesion sites in the extracellular matrix. The CytoSelect Cell Haptotaxis Assays are ideal for determining the migratory properties of cells. The 8 µm membrane pore size is ideal for epithelial cells and fibroblasts. The membrane serves as a barrier to distinguish between migratory and non-migratory cells. |
|||
CytoSelect 24-well Cell Haptotaxis Assay (8 µm), COL-coated, Fluorometric |
|||
CBA-101-COL | Cell Biolabs | 12 assays | 714 EUR |
Description: Cell haptotaxis describes cell migration toward or along a gradient of chemoattractants or adhesion sites in the extracellular matrix. The CytoSelect Cell Haptotaxis Assays are ideal for determining the migratory properties of cells. The 8 µm membrane pore size is ideal for epithelial cells and fibroblasts. The membrane serves as a barrier to distinguish between migratory and non-migratory cells. |
|||
Human GTP- binding protein RAD, RRAD ELISA KIT |
|||
ELI-35549h | Lifescience Market | 96 Tests | 988.8 EUR |
CytoSelect 96-Well Hematopoietic Colony Forming Cell Assay (5 x 96 assays) |
|||
CBA-320-5 | Cell Biolabs | 5 x 96 assays | 2536.8 EUR |
Description: Hematopoietic stem cells (HSCs) are well-characterized, tissue-specific stem cells that are responsible for the lifelong maintenance of the hematopoietic system. HSCs or hematopoietic progenitors known as colony-forming cells (CFCs) proliferate to form discrete colonies when cultured in a suitable 3D environment, such as methylcellulose supplemented with nutrients and cytokines. Our CytoSelect 96-Well Hematopoietic Colony Forming Cell Assay promotes the formation of HSC colonies in just 7-10 days. Cells can then be either quantified in a fluorescence plate reader or recovered from the semisolid medium for further downstream analysis. |
|||
CytoSelect 24-Well Cell Migration Assay (8 µm, Colorimetric Format), Trial Size |
|||
CBA-100-T | Cell Biolabs | 4 assays | 358.8 EUR |
Description: Chemotaxis describes the movement of cells toward or away from a chemical stimulus in their environment. Cell chemotaxis plays a pivotal role in the progression of cancer and other diseases. CytoSelect Cell Migration Assays are ideal for determining the chemotactic properties of cells. The 8 µm pore size is suitable for most cell types including epithelial cells, fibroblasts, and cancer cell lines. |
|||
CytoSelect 24-Well Cell Migration Assay (8 µm, Fluorometric Format), Trial Size |
|||
CBA-101-T | Cell Biolabs | 4 assays | 358.8 EUR |
Description: Chemotaxis describes the movement of cells toward or away from a chemical stimulus in their environment. Cell chemotaxis plays a pivotal role in the progression of cancer and other diseases. CytoSelect Cell Migration Assays are ideal for determining the chemotactic properties of cells. The 8 µm pore size is suitable for most cell types including epithelial cells, fibroblasts, and cancer cell lines. |
|||
CytoSelect 24-Well Cell Migration Assay (5 µm, Fluorometric Format), Trial Size |
|||
CBA-102-T | Cell Biolabs | 4 assays | 358.8 EUR |
Description: Chemotaxis describes the movement of cells toward or away from a chemical stimulus in their environment. Cell chemotaxis plays a pivotal role in the progression of cancer and other diseases. CytoSelect Cell Migration Assays are ideal for determining the chemotactic properties of cells. The 5 µm pore size is ideal for monocytes / macrophages. |
|||
CytoSelect 24-Well Cell Migration Assay (3 µm, Fluorometric Format), Trial Size |
|||
CBA-103-T | Cell Biolabs | 4 assays | 358.8 EUR |
Description: Chemotaxis describes the movement of cells toward or away from a chemical stimulus in their environment. Cell chemotaxis plays a pivotal role in the progression of cancer and other diseases. CytoSelect Cell Migration Assays are ideal for determining the chemotactic properties of cells. The 3 µm pore size is best for the smallest cells including neutrophils and other leukocytes. |
|||
Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
|||
K3480706 | ABM | 1.0 ug DNA | 200.4 EUR |
Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
|||
K3480707 | ABM | 1.0 ug DNA | 200.4 EUR |
Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
|||
K3480708 | ABM | 1.0 ug DNA | 200.4 EUR |
CytoSelect 96-Well Cell Transformation Assay (Soft Agar Colony Formation), Trial Size |
|||
CBA-130-T | Cell Biolabs | 24 assays | 463.2 EUR |
Description: Our CytoSelect 96-Well Cell Transformation Assay (Soft Agar Colony Formation) is suitable for measuring cell transformation where no downstream analysis is required. Cells are incubated in a semisolid agar medium for 7-8 days. The cells are then solubilized, lysed and detected using the included fluorescent dye in a fluorometric plate reader. |
|||
Human GTP-binding protein RAD (RRAD) ELISA Kit |
|||
abx385354-96tests | Abbexa | 96 tests | 1093.2 EUR |
CytoSelect 24-well Cell Migration and Invasion Assay (8 µm), Colorimetric, Combo Kit |
|||
CBA-100-C | Cell Biolabs | 2 x 12 assays | 1166.4 EUR |
Description: If you are assaying both invasive and migratory properties of your cells, order one of our economic CytoSelect Cell Migration / Invasion Assay Combo kits. These kits save you money compared to buying separate chemotaxis and cell invasion kits. Each 24-well combo kit provides sufficient reagents to perform 12 cell migration plus 12 cell invasion assays. |
|||
CytoSelect 24-well Cell Migration and Invasion Assay (8 µm), Colorimetric, Combo Kit |
|||
CBA-100-C-5 | Cell Biolabs | 10 x 12 assays | 4771.2 EUR |
Description: If you are assaying both invasive and migratory properties of your cells, order one of our economic CytoSelect Cell Migration / Invasion Assay Combo kits. These kits save you money compared to buying separate chemotaxis and cell invasion kits. Each 24-well combo kit provides sufficient reagents to perform 12 cell migration plus 12 cell invasion assays. |
|||
CytoSelect 24-well Cell Migration and Invasion Assay (8 µm), Fluorometric, Combo Kit |
|||
CBA-101-C | Cell Biolabs | 2 x 12 assays | 1166.4 EUR |
Description: If you are assaying both invasive and migratory properties of your cells, order one of our economic CytoSelect Cell Migration / Invasion Assay Combo kits. These kits save you money compared to buying separate chemotaxis and cell invasion kits. Each 24-well combo kit provides sufficient reagents to perform 12 cell migration plus 12 cell invasion assays. |
|||
CytoSelect 96-well Cell Migration and Invasion Assay (8 µm), Fluorometric, Combo Kit |
|||
CBA-106-C | Cell Biolabs | 2 x 96 assays | 1375.2 EUR |
Description: If you are assaying both invasive and migratory properties of your cells, order one of our economic CytoSelect Cell Migration / Invasion Assay Combo kits. These kits save you money compared to buying separate chemotaxis and cell invasion kits. Each 96-well combo kit provides sufficient reagents to perform 96 cell migration plus 96 cell invasion assays. |
Independent components associated to poor glycemic management (hemoglobinA1c ≥ 7%) have been being feminine, youthful aged, dwelling within the northeastern area, obtained care type hospitals decrease than regional stage, underneath common well being protection scheme, higher period of diabetes, increased physique mass index stage and absence of hypertension comorbidity.